Recent economic evaluation of 1-dose HPV vaccination uses unsupported assumptions
Emily A. Burger(University of Oslo), Ruanne V. Barnabas(Harvard University), Johannes Berkhof(Amsterdam University Medical Centers), Jean‐François Laprise(Université Laval), Marc Brisson(Centre hospitalier universitaire de Québec), Mark Jit(London School of Hygiene & Tropical Medicine), Iacopo Baussano(Centre International de Recherche sur le Cancer), John T. Schiller(National Cancer Institute), Kiesha Prem(National University of Singapore), Jane J. Kim(Boston Medical Center), Karen Canfell(Cancer Australia)
Cited by 1
Related Papers
The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study
|The Lancet Public Health|2020|2.3k
Age-dependent effects in the transmission and control of COVID-19 epidemics
|Nature Medicine|2020|1.9k
Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis
|The Lancet|2019|1.3k
Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study
|The Lancet Global Health|2020|1.2k
Projecting social contact matrices in 152 countries using contact surveys and demographic data
|PLoS Computational Biology|2017|1.1k